Registered Reports and Replication Funds: Rebuilding Scientific Credibility Through Structural Reform
Description
Restructure the scientific publication and funding system around two complementary reforms: (1) Registered Reports as Default: Funders and journals adopt the Registered Report format — where peer review and conditional acceptance occur before data collection, based on the quality of the question and methodology rather than the results.
This eliminates publication bias and p-hacking at the source. The top 50 journals by impact factor commit to offering Registered Report tracks by 2026. Major funders (NIH, Wellcome, ERC) require pre-registration for all clinical and social science grants above $250K.
(2) Global Replication Fund: A $2B annual fund — co-financed by major science funders — dedicated exclusively to replication studies of high-impact findings. Replication studies published in dedicated high-prestige venues with full career credit. Target: replicate the top 1,000 most-cited findings across high-stakes fields within 10 years.
Implementation Pathway
Phase 1 (2025–2027)
- • Top 50 journals launch Registered Report tracks
- • NIH and Wellcome mandate pre-registration for clinical trials and social science grants
- • Global Replication Fund launches at $500M/year
Phase 2 (2027–2031)
- • Registered Reports become majority format in high-impact journals
- • Replication Fund reaches $2B/year
- • University promotion criteria updated to credit replication contributions
Phase 3 (2031+)
- • Full integration into global science funding norms
- • Annual Reproducibility Index published for all major disciplines
Required Resources
Impact Analysis
Overall Net Impact
Combined analysis across all timeframes
Short-term
0-2 years
No benefits identified
No harms identified
Mid-term
3-10 years
No benefits identified
No harms identified
Long-term
10+ years
No benefits identified
No harms identified
Discussion
Discussion (1)
Registered Reports are ready to scale now — the infrastructure exists, 250+ journals already offer the format, and the evidence of effect is solid (publication bias effectively eliminated in RR studies). The bottleneck is funder mandates. If NIH, Wellcome Trust, and ERC simultaneously mandated RR format for funded research, adoption would cascade. The replication fund complement is essential — without dedicated funding, replications don't happen regardless of intent. This is one of the highest-leverage, lowest-cost interventions on the platform.